JPS51125345A - Novel oxime ether compound* process for preparation thereof and antiidepression agent - Google Patents

Novel oxime ether compound* process for preparation thereof and antiidepression agent

Info

Publication number
JPS51125345A
JPS51125345A JP51029394A JP2939476A JPS51125345A JP S51125345 A JPS51125345 A JP S51125345A JP 51029394 A JP51029394 A JP 51029394A JP 2939476 A JP2939476 A JP 2939476A JP S51125345 A JPS51125345 A JP S51125345A
Authority
JP
Japan
Prior art keywords
antiidepression
agent
preparation
ether compound
oxime ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51029394A
Other languages
English (en)
Other versions
JPS6026776B2 (ja
Inventor
Berunarudasu Anton Hendorikasu
Kuraasusen Fuorukeruto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of JPS51125345A publication Critical patent/JPS51125345A/ja
Publication of JPS6026776B2 publication Critical patent/JPS6026776B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP51029394A 1975-03-20 1976-03-19 新規オキシムエーテル化合物 Expired JPS6026776B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.
NL7503310 1975-03-20

Publications (2)

Publication Number Publication Date
JPS51125345A true JPS51125345A (en) 1976-11-01
JPS6026776B2 JPS6026776B2 (ja) 1985-06-25

Family

ID=19823424

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51029394A Expired JPS6026776B2 (ja) 1975-03-20 1976-03-19 新規オキシムエーテル化合物

Country Status (27)

Country Link
US (1) US4085225A (ja)
JP (1) JPS6026776B2 (ja)
AR (2) AR211011A1 (ja)
AT (1) AT340895B (ja)
AU (1) AU505358B2 (ja)
BE (1) BE839744A (ja)
CA (1) CA1076142A (ja)
CH (4) CH626057A5 (ja)
DD (1) DD128332A5 (ja)
DE (1) DE2610886A1 (ja)
DK (1) DK144942C (ja)
ES (1) ES446192A1 (ja)
FI (1) FI61875C (ja)
FR (1) FR2304336A1 (ja)
GB (1) GB1535226A (ja)
GR (1) GR60052B (ja)
HU (1) HU171030B (ja)
IE (1) IE43768B1 (ja)
IL (1) IL49238A (ja)
IT (1) IT1063064B (ja)
MX (1) MX9203723A (ja)
NL (1) NL7503310A (ja)
PL (3) PL101951B1 (ja)
SE (1) SE410312B (ja)
SU (3) SU635867A3 (ja)
YU (1) YU39345B (ja)
ZA (1) ZA761434B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015526507A (ja) * 2012-08-29 2015-09-10 エステックファーマ カンパニー，リミテッド フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU6776196A (en) * 1995-08-16 1997-03-12 Eli Lilly And Company Potentiation of serotonin response
IN182588B (ja) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (ja) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
CA2405025A1 (en) * 2000-04-24 2001-11-01 Aryx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
CN105712985A (zh) * 2001-10-12 2016-06-29 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
MXPA06002789A (es) 2003-09-12 2006-06-14 Pfizer Combinaciones que comprenden ligandos alfa-2-delta.
EP1689721B1 (en) * 2003-11-26 2010-07-14 Pfizer Products Inc. Aminopyrazole derivatives as gsk-3 inhibitors
EP1691811B1 (en) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
CN1946906A (zh) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 用于墙、护墙和类似物的饰面
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US9597314B2 (en) 2005-03-22 2017-03-21 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids for treating premenstrual disorders
WO2006116150A1 (en) 2005-04-22 2006-11-02 Wyeth Dihydrobenzofuran derivatives and uses thereof
MX2007013179A (es) * 2005-04-22 2008-01-16 Wyeth Corp Formas cristalinas de clorhidrato de {[(2r)-7-(diclorofenil)-5- fluoro-2,3-dihidro-1-benzofurano-2-il]metil}amina.
EP1871358A1 (en) 2005-04-22 2008-01-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
BRPI0610037A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de dihidrobenzofurano e uso dos mesmos
EP1904843A2 (en) 2005-07-08 2008-04-02 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
AU2006270039B2 (en) 2005-07-19 2013-07-04 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1998773A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware New therapeutic combinations for the treatment of depression
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
WO2008030651A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100016274A1 (en) * 2006-09-14 2010-01-21 Koppel Gary A Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
US20080171750A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation Of Neurogenesis With Use of Modafinil
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
WO2010021681A2 (en) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
JP5759470B2 (ja) 2009-10-23 2015-08-05 ヤンセン ファーマシューティカ エヌ．ベー． オレキシン受容体調節因子としての二置換オクタヒドロピロロ［３，４−ｃ］ピロール
WO2011071995A2 (en) 2009-12-08 2011-06-16 Case Western Reserve University Compounds and methods of treating ocular disorders
CN103269584B (zh) 2010-07-01 2017-05-03 阿泽凡药物公司 用于治疗创伤后应激障碍的方法
KR20140045925A (ko) 2011-03-17 2014-04-17 루핀 리미티드 선택적 세로토닌 재흡수 억제제의 방출조절형 약제학적 조성물
EP2981518B1 (en) * 2013-04-03 2021-03-03 ZCL Chemicals Ltd. "an improved process for the preparation of fluvoxamine maleate"
PL3104847T3 (pl) 2014-02-07 2021-07-05 Támogatott Kutatócsoportok Irodája Nowe zastosowanie związków agonistycznych receptora sigma-1
MX2016012645A (es) 2014-03-28 2017-01-11 Azevan Pharmaceuticals Inc Composiciones y metodos para tratar enfermedades neurodegenerativas.
KR102559922B1 (ko) 2016-03-10 2023-07-25 얀센 파마슈티카 엔.브이. 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법
ES2926179T3 (es) 2016-11-24 2022-10-24 Sigmadrugs Kutato Korlatolt Feleloessegue Tarsasag Utilización de composiciones para la conservación de órganos/tejidos
WO2019055913A1 (en) 2017-09-15 2019-03-21 Azevan Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN INJURY
BR112022000992A2 (pt) 2019-07-19 2022-06-14 Arx Llc Regimes de tratamento de dexmedetomidina não sedantes
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015526507A (ja) * 2012-08-29 2015-09-10 エステックファーマ カンパニー，リミテッド フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法

Also Published As

Publication number Publication date
GB1535226A (en) 1978-12-13
SU635867A3 (ru) 1978-11-30
FR2304336B1 (ja) 1979-09-28
CA1076142A (en) 1980-04-22
YU39345B (en) 1984-10-31
DK144942B (da) 1982-07-12
DK144942C (da) 1982-12-06
FI760699A (ja) 1976-09-21
CH626057A5 (ja) 1981-10-30
HU171030B (hu) 1977-10-28
CH629477A5 (de) 1982-04-30
SE410312B (sv) 1979-10-08
AT340895B (de) 1978-01-10
CH629184A5 (de) 1982-04-15
SU620206A3 (ru) 1978-08-15
BE839744A (fr) 1976-09-20
YU71476A (en) 1982-10-31
DE2610886A1 (de) 1976-10-07
IE43768L (en) 1976-09-20
CH629761A5 (de) 1982-05-14
DD128332A5 (de) 1977-11-09
IL49238A (en) 1978-08-31
US4085225A (en) 1978-04-18
AR211011A1 (es) 1977-10-14
PL100614B1 (pl) 1978-10-31
AU505358B2 (en) 1979-11-15
DK115976A (da) 1976-09-21
GR60052B (en) 1978-04-04
IT1063064B (it) 1985-02-11
ES446192A1 (es) 1977-10-01
PL100052B1 (pl) 1978-08-31
AU1214776A (en) 1977-09-22
PL101951B1 (pl) 1979-02-28
FI61875C (fi) 1982-10-11
AR211153A1 (es) 1977-10-31
FI61875B (fi) 1982-06-30
NL7503310A (nl) 1976-09-22
IE43768B1 (en) 1981-05-20
JPS6026776B2 (ja) 1985-06-25
ATA195476A (de) 1977-05-15
IL49238A0 (en) 1976-05-31
DE2610886C2 (ja) 1987-09-24
ZA761434B (en) 1977-10-26
FR2304336A1 (fr) 1976-10-15
SU645559A3 (ru) 1979-01-30
SE7603341L (sv) 1976-09-21
MX9203723A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
JPS51125345A (en) Novel oxime ether compound* process for preparation thereof and antiidepression agent
GB1547802A (en) Process for the preparation of poly-phenyleneterephthalamide
IL58540A0 (en) Process for the preparation of steroids
PT65486B (en) Process for the preparation of carbonil-substituted 1-sulfonylbenzimidazoles
GB1517423A (en) Process for the preparation of diaryl-carbonates
GB1518383A (en) Process for the preparation of hydroxybenzaldehydes
PT64878A (en) Process for the preparation of new indolylalkylpiperidines
PT65255B (en) Process for the preparation of 11-desoxy-16-aryloxy-w-tetranorprostaglandins
YU39275B (en) Process for the preparation of propargyl-2-phenylamino-imidazolines-(2)
CH608786A5 (en) Process for the preparation of acetoacetylarylamides
PT65464A (en) Process for preparation of novel antiinflamatory agents
JPS5253857A (en) Novel oxazolidinee22one compound and preparation thereof
GB1534077A (en) Process for the preparation of 5-acetoacetylamino-benzimidazolone
JPS51113810A (en) Novel hydroxylamines preparation method and application thereof
JPS51125346A (en) Novel oxime ether compound* process for preparation thereof and antiidepression agent
JPS51138640A (en) Novel oxime ether compound*process for preparation thereof and antiidepression agent
JPS5288300A (en) Novel compound and process for preparing same
JPS51138639A (en) Novel oxime ether compound*process for preparation thereof and antiidepression agent
PT65448B (en) Process for the preparation of new nitriles
JPS5217434A (en) Novel compound*process for preparation thereof and pharmaceutical composition
JPS5239682A (en) Thiaxanthene compound and preparation method thereof
CH613607A5 (en) Ensiling agent and process for preparation thereof
JPS5278894A (en) Cephalospoline compound and process for preparing same
ZA765984B (en) 2-azetidinone compounds and process for preparation thereof
JPS5283356A (en) Pharmaceutical composition novel compound containing therein and process for preparing same